Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sikarin PCLBKK:SKR -1.25%84 EV-to-FCF is 15.69 as of Aug. 04, 2026, which is 55% below its 10-year median of 34.73. GuruFocus rates BKK:SKR with a GF Score™ of 84/100 and a GF Value™ of ฿9.13 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Sikarin PCL ranks better than 55.06% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sikarin PCL's Enterprise Value is ฿15,222 Mil.
Sikarin PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ฿970 Mil. Therefore, Sikarin PCL's EV-to-FCF for today is 15.69.
The historical rank and industry rank for Sikarin PCL's EV-to-FCF or its related term are showing as below:
BKK:SKR'
s EV-to-FCF Range Over the Past 10 Years
Min: 11.57 Med: 34.73 Max: 696.41
Current: 15.79
During the past 13 years, the highest EV-to-FCF of Sikarin PCL was 696.41. The lowest was 11.57. And the median was 34.73.
BKK:SKR's EV-to-FCF is ranked better than 55.06% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.23
vs BKK:SKR: 15.79
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sikarin PCL's PE Ratio (TTM) for today is calculated as:
Sikarin PCL's share price for today is ฿7.90.
Sikarin PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.324.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sikarin PCL EV-to-FCF Related Terms
Sikarin PCL EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Sikarin PCL's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Sikarin PCL's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sikarin PCL EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sikarin PCL's EV-to-FCF falls into.
Sikarin PCL's current Enterprise Value is ฿15,222 Mil.
Sikarin PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿970 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sikarin PCL (BKK:SKR) has a EV-to-FCF of 15.69 as of Aug. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sikarin PCL and its competitors. This is 55% below median its historical median of 34.73. Over the past decade, Sikarin PCL's EV-to-FCF has ranged from 11.57 to 696.41. According to the industry distribution chart, Sikarin PCL ranks #182 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 44.9%.
Is Sikarin PCL's EV-to-FCF too high?
Sikarin PCL's current EV-to-FCF of 15.69 is 55% below median its 10-year median of 34.73. Over the past 10 years, this metric has ranged from a low of 11.57 to a high of 696.41. The Healthcare Providers & Services industry median EV-to-FCF is 18.23. Sikarin PCL's value of 15.69 is 13.9% below this industry median. Based on the distribution chart, Sikarin PCL ranks #182 out of 405 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sikarin PCL has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #182 out of 405 companies for EV-to-FCF. This puts Sikarin PCL in the upper half of its industry. The industry median EV-to-FCF is 18.23. Sikarin PCL's value of 15.69 is 13.9% below this benchmark. Historically, Sikarin PCL's own EV-to-FCF has ranged from 11.57 to 696.41 over the past decade. While the company's 10-year median is 34.73 vs. the industry median of 18.23, Sikarin PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.23, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sikarin PCL's current EV-to-FCF of 15.69 is 13.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current EV-to-FCF is 15.69, which is 55% below median its own 10-year median of 34.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿9.13, compared to a current price of ฿7.90 — trading 13.5% below its estimated fair value. The current EV-to-FCF is 15.69, which is 55% below median its 10-year median of 34.73 and 13.9% below the Healthcare Providers & Services industry median of 18.23. Sikarin PCL's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR), the current EV-to-FCF is 15.69 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sikarin PCL (BKK:SKR) Overvalued in 2026?
Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued.
The current stock price of ฿7.90 is trading 13.5% below its estimated GF Value™ of ฿9.13.
GuruFocus considers Sikarin PCL to be Modestly Undervalued.
Key valuation signals for BKK:SKR:
EV-to-FCF: 15.69 (55% below median its 10-year median of 34.73)
GF Value™: ฿9.13 vs. price of ฿7.90 (13.5% below fair value)
Industry Position: 13.9% below the Healthcare Providers & Services median (#182 of 405)
No single metric tells the full story. See the BKK:SKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
84GF Score
Get the complete analysis for BKK:SKR
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKR has been successfully added to your 
